Novo Integrated Sciences(NVOS) - 2023 Q2 - Quarterly Report

Washington D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___, 20, to __, 20. UNITED STATES SECURITIES AND EXCHANGE COMMISSION (State or Other Jurisdiction of Incorporation or Organization) 11120 NE 2nd Street, Suite 100 Bellevue, Washington 98004 (Address of Princ ...